Evidence map›Paper›PMID 30337714›Full record

ArticleEuropean journal of clinical nutrition2019

Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Heather A Ward, Julia Whitman, David C Muller, Mattias Johansson, Paula Jakszyn, Elisabete Weiderpass, Domenico Palli, Anouar Fanidi, Roel Vermeulen, Anne Tjønneland and 37 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in European journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Iron and Cancer.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Iron metabolism in colorectal cancer.Frontiers in oncology · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 12 countries.

Heather A WardSchool of Public Health, Imperial College London, London, UK. heather.ward@imperial.ac.uk.
Julia WhitmanSchool of Public Health, Imperial College London, London, UK.
David C MullerSchool of Public Health, Imperial College London, London, UK.
Mattias JohanssonInternational Agency for Research on Cancer, Lyon, France.
Paula JakszynUnit of Nutrition, Environment and Cancer, Catalan Institute of Oncology, Barcelona, Spain.
Elisabete WeiderpassDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0003-2237-0128
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
Anouar FanidiInternational Agency for Research on Cancer, Lyon, France.
Roel VermeulenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Anne TjønnelandDanish Cancer Society Research Centre, Copenhagen, Denmark.
Louise HansenDanish Cancer Society Research Centre, Copenhagen, Denmark.
Christina C DahmSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kim OvervadSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Gianluca SeveriHuman Genetics Foundation, Torino, Italy.
Marie-Christine Boutron-RuaultCESP Inserm, Facultés de Medicine Université Paris-Sud, UVSQ, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
Aurélie AffretCESP Inserm, Facultés de Medicine Université Paris-Sud, UVSQ, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Renee FortnerDivision of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Carlo La VecchiaHellenic Health Foundation, Athens, Greece.
Anastasia KotanidouHellenic Health Foundation, Athens, Greece.
Franco BerrinoFondazione IRCCS National Cancer Institute, Milan, Italy.
Vittorio KroghFondazione IRCCS National Cancer Institute, Milan, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital, ASP Ragusa, Italy.
Fulvio RicceriDepartment of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.
Salvatore PanicoDepartment of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
H Bas Bueno-de-MesquitaSchool of Public Health, Imperial College London, London, UK.
Petra H PeetersSchool of Public Health, Imperial College London, London, UK.
Therese Haugdahl NøstDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Torkjel M SandangerDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Jose Ramón QuirósPublic Health Directorate, Asturias, Spain.
Antonio AgudoUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
Miguel Rodríguez-BarrancoEscuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Nerea LarrañagaCIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Jose Maria HuertaCIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Eva ArdanazCIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Isabel DrakeDepartment of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Hans BrunnströmDepartment of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Malmö, Sweden.
Mikael JohanssonDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Kjell GrankvistDepartment of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0003-4289-2097
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health University of Oxford, Oxford, UK.
Heinz FreislingInternational Agency for Research on Cancer, Lyon, France.
Magdalena StepienInternational Agency for Research on Cancer, Lyon, France.
Melissa A MerrittSchool of Public Health, Imperial College London, London, UK.
Elio RiboliSchool of Public Health, Imperial College London, London, UK.
Amanda J CrossSchool of Public Health, Imperial College London, London, UK.
Imperial College London · GBCentre international de recherche sur le cancer · FRUniversité Paris-Sud · FRAarhus University · DKDanish Cancer Society · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Cancer Research Center · DEUiT The Arctic University of Norway · NOAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESFederico II University Hospital · ITGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESHellenic Health Foundation · GRInstitut Català d'Oncologia · ESInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESLund University · SEMalmö University · SE

Funding

Cancer Research UK 14136Cancer Research UK 16491Cancer Research UK 25004Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

backgroundEpidemiological studies suggest that haem iron, which is found predominantly in red meat and increases endogenous formation of carcinogenic N-nitroso compounds, may be positively associated with lung cancer. The objective was to examine the relationship between haem iron intake and lung cancer risk using detailed smoking history data and serum cotinine to control for potential confounding.

methodsIn the European Prospective Investigation into Cancer and Nutrition (EPIC), 416,746 individuals from 10 countries completed demographic and dietary questionnaires at recruitment. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident lung cancer (n = 3731) risk relative to haem iron, non-haem iron, and total dietary iron intake. A corresponding analysis was conducted among a nested subset of 800 lung cancer cases and 1489 matched controls for whom serum cotinine was available.

resultsHaem iron was associated with lung cancer risk, including after adjustment for details of smoking history (time since quitting, number of cigarettes per day): as a continuous variable (HR per 0.3 mg/1000 kcal 1.03, 95% CI 1.00-1.07), and in the highest versus lowest quintile (HR 1.16, 95% CI 1.02-1.32; trend across quintiles: P = 0.035). In contrast, non-haem iron intake was related inversely with lung cancer risk; however, this association attenuated after adjustment for smoking history. Additional adjustment for serum cotinine did not considerably alter the associations detected in the nested case-control subset.

conclusionsGreater haem iron intake may be modestly associated with lung cancer risk.

Indexed as

Nutrition AssessmentCase-Control StudiesCohort StudiesEuropeFemaleHemeHumansIron, DietaryLung NeoplasmsMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk AssessmentRisk FactorsHemeIron, Dietary

Identifiers

PMID30337714
PMCPMC6372073
OpenAlexW2897362114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.